GSEP
ZBH icon

Golden State Equity Partners’s Zimmer Biomet ZBH Stock Holding History

Golden State Equity Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-97
Closed -$8.77K – 1796
2026
Q1 		$8.77K Buy
+97
New +$8.9K ﹤0.01% 1338
2022
Q1 		$1.23M Buy
+9,601
New +$1.16M 0.62% 44

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Golden State Equity Partners's ZBH Position: Q2 2026 in Review

Golden State Equity Partners sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 97 shares — an estimated $8.77K sold.

Golden State Equity Partners first reported a position in ZBH in Q1 2022 and held it in 2 quarters. The position peaked at $1.23M in Q1 2022. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Golden State Equity Partners reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 97 Zimmer Biomet shares in Q2 2026, an estimated $8.77K.
  • Golden State Equity Partners first reported a position in Zimmer Biomet in Q1 2022 and held it in 2 quarters.
  • Golden State Equity Partners's Zimmer Biomet position peaked at $1.23M in Q1 2022.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.